Alpha-blocker and 5-alpha reductase inhibitor combination

This page covers all Alpha-blocker and 5-alpha reductase inhibitor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 adrenergic receptor and 5-alpha reductase enzyme.

Targets

Alpha-1 adrenergic receptor and 5-alpha reductase enzyme

Phase 3 pipeline (1)

• Maintenance of alpha-blocker and 5-ARI · Gangnam Severance Hospital · Urology
  This combination therapy maintains symptom relief in benign prostatic hyperplasia by combining alpha-blocker-mediated smooth muscle relaxation with 5-alpha reductase inhibitor-mediated reduction of prostate volume.

Patent intelligence

• alpha blocker and 5 alpha reductase inhibitor combination patent landscape — aggregated cliff calendar, attackable patents, originator estates